Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens

Autor: Meneceur, Sarah, Löck, Steffen, Gudziol, Volker, Hering, Sandra, Bütof, Rebecca, Rehm, Maximilian, Baumann, Michael, Krause, Mechthild, von Neubeck, Cläre

Publikováno v: In Radiotherapy and Oncology August 2019 137:24-31

Corrigendum to “Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens” [Radiother. Oncol. 137 (2019) 24–31]

Autor: Meneceur, Sarah, Löck, Steffen, Gudziol, Volker, Hering, Sandra, Bütof, Rebecca, Rehm, Maximilian, Baumann, Michael, Krause, Mechthild, von Neubeck, Cläre

Publikováno v: In Radiotherapy and Oncology June 2023 183

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Epigenetic Priming and Development of New Combination Therapy Approaches.

Autor: Meneceur S; Department of Urology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany., Grunewald CM; Department of Urology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany., Niegisch G; Department of Urology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany., Hoffmann MJ; Department of Urology, Medical Faculty and University Hospital, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany. michele.hoffmann@med.uni-duesseldorf.de.; German Study Group of Bladder Cancer (DFBK e.V.), Munich, Germany. michele.hoffmann@med.uni-duesseldorf.de.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2684, pp. 259-281.